ArticleBlood research2021

Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity.

Junshik Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.